SLC2A1 and Alzheimer disease: Additionally, the GLUT1 and GLUT3 expression levels were reduced in six brain regions of AD patients, and the decreased GLUT3 levels in certain neurons compromised the glucose availability and may be responsible for the deficits in glucose metabolism [44].